Female Urology

Latest News

AUGS Research Agenda
AUGS Research Agenda

September 26th 2023

To acknowledge the need for increased research funding directed towards women’s health, beyond maternity and reproductive care, AUGS has established the National Urogynecology Research Agenda.

What the SWIU Census reveals about the state of women in urology
What the SWIU Census reveals about the state of women in urology

September 20th 2023

Cleveland Clinic: What trans women should know about prostate cancer
Cleveland Clinic: What trans women should know about prostate cancer

September 17th 2023

Vaginal estrogen improves vaginal atrophy, has no effect on pelvic organ prolapse recurrence
Vaginal estrogen improves vaginal atrophy, has no effect on pelvic organ prolapse recurrence

August 17th 2023

FDA grants priority review to cefepime-taniborbactam for complicated UTIs
FDA grants priority review to cefepime-taniborbactam for complicated UTIs

August 15th 2023

Latest CME Events & Activities

7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)

Register Now!

5th Annual Precision Medicine Symposium: An Illustrated Tumor Board

Register Now!

Clinical Conversations With the Cancer Care Team: Discussing the Impact of Social Inequities on Treatment Outcomes in Triple-Negative Breast Cancer

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Oncology Town Hall™: Primary Investigators Present Key Abstracts in Genitourinary Malignancies from Paris

View More

Expert Perspectives on Emerging CDK4/6 Inhibitor Strategies in Advanced Prostate Cancer Management Settings

View More

New York GU 17th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Register Now!

Patient, Provider, & Caregiver Connection: Individualizing Care in Multiple Sclerosis – Understanding Patient Challenges and the Role of Innovative Treatment

View More

Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis

View More

Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy

View More

How the Experts Treat NMIBC During a BCG Shortage—Integrating Recent Approvals and Investigational Therapies

View More

Medical Crossfire®: Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?

View More

Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies

View More

23rd Annual International Congress on the Future of Breast Cancer® East

Register Now!

Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies

View More

Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer

View More

4th Annual International Congress on the Future of Women’s Health™

View More

Medical Crossfire®: How Will Emerging Data Inform Treatment Planning for Patients With Prostate Cancer in the Community?

View More

More News

© 2023 MJH Life Sciences

All rights reserved.